» Articles » PMID: 31120475

Pediatric Thyroid Cancer Incidence and Mortality Trends in the United States, 1973-2013

Overview
Date 2019 May 24
PMID 31120475
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: The incidence of thyroid cancer is increasing by 3% annually. This increase is often thought to be attributable to overdiagnosis in adults. A previous study reported a 1.1% annual increase in the incidence of pediatric thyroid cancer. However, the analysis was limited to the period from 1973 to 2004 and was performed in a linear fashion, which does not account for changes in incidence trends over time.

Objective: To analyze trends in pediatric thyroid cancer incidence based on demographic and tumor characteristics at diagnosis.

Design, Setting, And Participants: This cross-sectional study included individuals younger than 20 years who had a diagnosis of thyroid cancer in the Surveillance, Epidemiology, and End Results (SEER) 9 database from 1973 to 2013. Cases of thyroid cancer were identified using the International Classification of Diseases for Oncology, Third Edition and were categorized by histologic type, stage, and tumor size.

Main Outcomes And Measures: Annual percent change (APC) in the incidence rates was calculated using joinpoint regression analysis.

Results: Among 1806 patients included in the analysis, 1454 (80.5%) were female and 1503 (83.2%) were white; most patients were aged 15 to 19 years. The overall incidence rates of thyroid cancer increased annually from 0.48 per 100 000 person-years in 1973 to 1.14 per 100 000 person-years in 2013. Incidence rates gradually increased from 1973 to 2006 (APC, 1.11%; 95% CI, 0.56%-1.67%) and then markedly increased from 2006 to 2013 (APC, 9.56%; 95% CI, 5.09%-14.22%). The incidence rates of large tumors (>20 mm) gradually increased from 1983 to 2006 (APC, 2.23%; 95% CI, 0.93%-3.54%) and then markedly increased from 2006 to 2013 (APC, 8.84%; 95% CI, 3.20%-14.79%); these rates were not significantly different from incidence rates of small (1-20 mm) tumors. The incidence rates of regionally extended thyroid cancer gradually increased from 1973 to 2006 (APC, 1.44%; 95% CI, 0.68%-2.21%) and then markedly increased from 2006 to 2013 (APC, 11.16%; 95% CI, 5.26%-17.40%); these rates were not significantly different from the incidence rates of localized disease.

Conclusions And Relevance: The incidence rates of pediatric thyroid cancer increased more rapidly from 2006 to 2013 than from 1973 to 2006. The findings suggest that there may be a co-occurring increase in thyroid cancer in the pediatric population in addition to enhanced detection.

Citing Articles

Clinical characteristics, surgical approaches, and prognosis of follicular and papillary thyroid cancer in children and adolescents: a retrospective cohort study.

Liu Y, Meng T, Ma S, Zheng Y, Miao Y, Zhang T Pediatr Surg Int. 2025; 41(1):89.

PMID: 40019558 DOI: 10.1007/s00383-025-05990-3.


The Impact of Radioactive Iodine on Outcomes Among Pediatric and Adolescent Thyroid Cancer Patients: A SEER Database Analysis.

Persons E, Hussein M, Herrera M, Pinion D, Webster A, Pineda E Cancers (Basel). 2025; 17(1.

PMID: 39796737 PMC: 11720182. DOI: 10.3390/cancers17010107.


Concurrent Association of Multifocality, Bilaterality, and Recurrence in Pediatric Papillary Thyroid Cancer Patients.

Cho J, Rah C, Kim W, Lee Y, Kim S, Baek J Yonsei Med J. 2025; 66(1):43-50.

PMID: 39742884 PMC: 11704237. DOI: 10.3349/ymj.2023.0582.


Global burden of thyroid cancer in 2022: Incidence and mortality estimates from GLOBOCAN.

Lyu Z, Zhang Y, Sheng C, Huang Y, Zhang Q, Chen K Chin Med J (Engl). 2024; 137(21):2567-2576.

PMID: 39261986 PMC: 11557048. DOI: 10.1097/CM9.0000000000003284.


Outcomes of Differentiated Thyroid Cancer in Children and Adolescents at King Abdulaziz Medical City, Jeddah.

Nasser T, Altirkistani B, Bougis S, Abu Ghasham A, Nafadi I Cureus. 2024; 16(8):e65992.

PMID: 39100815 PMC: 11295254. DOI: 10.7759/cureus.65992.


References
1.
Kent W, Hall S, Isotalo P, Houlden R, George R, Groome P . Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007; 177(11):1357-61. PMC: 2072986. DOI: 10.1503/cmaj.061730. View

2.
Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M, Dal Maso L . Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med. 2016; 375(7):614-7. DOI: 10.1056/NEJMp1604412. View

3.
Enewold L, Zhu K, Ron E, Marrogi A, Stojadinovic A, Peoples G . Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009; 18(3):784-91. PMC: 2676561. DOI: 10.1158/1055-9965.EPI-08-0960. View

4.
Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S . Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer. 2012; 132(5):1222-6. PMC: 3910094. DOI: 10.1002/ijc.27749. View

5.
Chen A, Jemal A, Ward E . Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009; 115(16):3801-7. DOI: 10.1002/cncr.24416. View